Reversible Ser/Thr SHIP phosphorylation: A new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues

BioEssays

Volumn 34, Issue 8, 2012, Pages 634-642

  Edimo, William's Elong ^a   Janssens, Veerle ^b   Waelkens, Etienne ^b   Erneux, Christophe ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Inositol polyphosphate 5 phosphatase; Phosphatidylinositol metabolism; Protein phosphatases; SHIP1; SHIP2; Signal transduction

Indexed keywords

ACTIN; INSULIN; MICRORNA 205; PHOSPHATASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOTYROSINE; PLATELET DERIVED GROWTH FACTOR; POLO LIKE KINASE; PROTEIN KINASE B; PROTEIN SH2; PROTEIN SHIP1; PROTEIN SHIP2; PROTEIN TYROSINE PHOSPHATASE SHP; SERINE; SYNAPTOJANIN; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA CELL; BASAL METABOLIC RATE; BONE GROWTH; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; DIABETES MELLITUS; ENZYME ACTIVITY; GENE DELETION; HEMATOPOIETIC CELL; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IN VIVO STUDY; KNOCKOUT MOUSE; LEUKEMOGENESIS; LIPID DIET; MOLECULAR INTERACTION; MYELOPROLIFERATIVE DISORDER; NEOPLASM; NEUROTRANSMISSION; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SUBUNIT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; ZEBRA FISH;

ANIMALS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; ENZYME ACTIVATION; HUMANS; MICE; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN INTERACTION MAPPING; PTEN PHOSPHOHYDROLASE; SERINE; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; THREONINE; TYROSINE;

EID: 84863883711     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100195     Document Type: Article

References (82)

1. McCrea HJ, De Camilli P. 2009. Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 24: 8-16.
2. Chalhoub N, Baker SJ. 2009. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4: 127-50.
3. Kaneko K, Ueki K, Takahashi N, Hashimoto S, et al. 2010. Class IA phosphatidylinositol 3-kinase in pancreatic beta cells controls insulin secretion by multiple mechanisms. Cell Metab 12: 619-32.
4. Blero D, Payrastre B, Schurmans S, Erneux C. 2007. Phosphoinositide phosphatases in a network of signalling reactions. Pflugers Arch 455: 31-44.
5. Pirruccello M, De Camilli P. 2012. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochem Sci 37: 134-43.
6. Backers K, Blero D, Paternotte N, Zhang J, et al. 2003. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv Enzyme Regul 43: 15-28.
7. Erneux C, Edimo WE, Deneubourg L, Pirson I. 2011. SHIP2 multiple functions: a balance between a negative control of PtdIns(3, 4, 5)P level, a positive control of PtdIns(3, 4)P production, and intrinsic docking properties. J Cell Biochem 112: 2203-9.
8. Liu BA, Shah E, Jablonowski K, Stergachis A, et al. 2011. The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes. Sci Signal 4: ra83.
9. Damen JE, Liu L, Rosten P, Humphries RK, et al. 1996. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3, 4, 5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA 93: 1689-93.
10. Kavanaugh WM, Pot DA, Chin SM, Deuter-Reinhard M, et al. 1996. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr Biol 6: 438-45.
11. Wisniewski D, Strife A, Swendeman S, Erdjument-Bromage H, et al. 1999. A novel SH2-containing phosphatidylinositol 3, 4, 5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93: 2707-20.
12. Pesesse X, Dewaste V, De Smedt F, Laffargue M, et al. 2001. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3, 4, 5-trisphosphate in EGF-stimulated COS-7 cells. J Biol Chem 276: 28348-55.
13. Hamilton MJ, Ho VW, Kuroda E, Ruschmann J, et al. 2011. Role of SHIP in cancer. Exp Hematol 39: 2-13.
14. Salmena L, Carracedo A, Pandolfi PP. 2008. Tenets of PTEN tumor suppression. Cell 133: 403-14.
15. Manning BD, Cantley LC. 2007. AKT/PKB signaling: navigating downstream. Cell 129: 1261-74.
16. Leslie NR, Dixon MJ, Schenning M, Gray A, et al. 2012. Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases. Adv Enzyme Regul 52: 205-13.
17. Fedele CG, Ooms LM, Ho M, Vieusseux J, et al. 2010. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc Natl Acad Sci USA 107: 22231-6.
18. Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, et al. 2009. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 16: 115-25.
19. Leung WH, Tarasenko T, Bolland S. 2009. Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes. Immunol Res 43: 243-51.
20. Helgason CD, Damen JE, Rosten P, Grewal R, et al. 1998. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12: 1610-20.
21. Sleeman MW, Wortley KE, Lai KM, Gowen LC, et al. 2005. Absence of the lipid phosphatase SHIP2 confers resistance to diary obesity. Nat Med 11: 199-205.
22. Elong Edimo W, Derua R, Janssens V, Nakamura T, et al. 2011. Evidence of SHIP2 S132 phosphorylation, its nuclear localization and stability. Biochem J 439: 391-401.
23. Nalaskowski MM, Metzner A, Brehm MA, Labiadh S, et al. 2011. The inositol 5-phosphatase SHIP1 is a nucleo-cytoplasmic shuttling protein and enzymatically active in cell nuclei. Cell Signal 24: 621-8.
24. Barlow CA, Laishram RS, Anderson RA. 2010. Nuclear phosphoinositides: a signaling enigma wrapped in a compartmental conundrum. Trends Cell Biol 20: 25-35.
25. Martelli AM, Ognibene A, Buontempo F, Fini M, et al. 2011. Nuclear phosphoinositides and their roles in cell biology and disease. Crit Rev Biochem Mol Biol 46: 436-57.
26. Giuriato S, Blero D, Robaye B, Bruyns C, et al. 2002. SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line. Biochem Biophys Res Commun 296: 106-10.
27. Krystal G. 2000. Lipid phosphatases in the immune system. Semin Immunol 12: 397-403.
28. Taylor V, Wong M, Brandts C, Reilly L, et al. 2000. 5′ Phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol 20: 6860-71.
29. Nakatsu F, Perera RM, Lucast L, Zoncu R, et al. 2010. The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics. J Cell Biol 190: 307-15.
30. Batty IH, Van der Kaay J, Gray A, Telfer JF, et al. 2007. The control of phosphatidylinositol 3, 4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2. Biochem J 407: 255-66.
31. Vaillancourt M, Levasseur S, Tremblay ML, Marois L, et al. 2006. The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils. Cell Signal 18: 2022-32.
32. Giuriato S, Payrastre B, Drayer AL, Plantavid M, et al. 1997. Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. J Biol Chem 272: 26857-63.
33. Gratacap MP, Severin S, Chicanne G, Plantavid M, et al. 2007. Different roles of SHIP1 according to the cell context: the example of blood platelets. Adv Enzyme Regul 48: 240-52.
34. Desponts C, Ninos JM, Kerr WG. 2006. s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival. Stem Cells Dev 15: 641-6.
35. Tu Z, Ninos JM, Ma Z, Wang JW, et al. 2001. Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5′-phosphatase isoform that partners with the Grb2 adapter protein. Blood 98: 2028-38.
36. Ruschmann J, Ho V, Antignano F, Kuroda E, et al. 2010. Tyrosine phosphorylation of SHIP promotes its proteasomal degradation. Exp Hematol 38: 392-402, 402e1.
37. McPherson PS, Garcia EP, Slepnev VI, David C, et al. 1996. A presynaptic inositol-5-phosphatase. Nature 379: 353-7.
38. Lee SY, Wenk MR, Kim Y, Nairn AC, et al. 2004. Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc Natl Acad Sci USA 101: 546-51.
39. Olsen JV, Blagoev B, Gnad F, Macek B, et al. 2006. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-48.
40. Zhang J, Ravichandran KS, Garrison JC. 2010. A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5′-phosphatase (SHIP1). J Biol Chem 285: 34839-49.
41. Artemenko Y, Gagnon A, Ibrahim S, Sorisky A. 2007. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes. J Cell Physiol 211: 598-607.
42. Mellman DL, Gonzales ML, Song C, Barlow CA, et al. 2008. A PtdIns4, 5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs. Nature 451: 1013-7.
43. Leslie NR, Batty IH, Maccario H, Davidson L, et al. 2008. Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27: 5464-76.
44. Xu D, Yao Y, Jiang X, Lu L, et al. 2010. Regulation of PTEN stability and activity by Plk3. J Biol Chem 285: 39935-42.
45. Olsen JV, Vermeulen M, Santamaria A, Kumar C, et al. 2010. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3: ra3.
46. Torres J, Pulido R. 2001. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 276: 993-8.
47. Zwaenepoel K, Goris J, Erneux C, Parker PJ, et al. 2010. Protein phosphatase 2A PR130/B″alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling. FASEB J 24: 538-47.
48. 2+-dependent dephosphorylation of DARPP-32 by protein phosphatase 2A. Proc Natl Acad Sci USA 104: 9876-81.
49. 2+-binding EF-hand motifs in the B″/PR72 subunit of protein phosphatase 2A. J Biol Chem 278: 10697-706.
50. Janssens V, Derua R, Zwaenepoel K, Waelkens E, et al. 2009. Specific regulation of protein phosphatase 2A PR72/B" subunits by calpain. Biochem Biophys Res Commun 386: 676-81.
51. Crockett DK, Fillmore GC, Elenitoba-Johnson KS, Lim MS. 2005. Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics. Proteomics 5: 1250-62.
52. Janssens V, Goris J, Van HC. 2005. PP2A: the expected tumor suppressor. Curr Opin Genet Dev 15: 34-41.
53. Severin S, Gratacap MP, Lenain N, Alvarez L, et al. 2007. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest 117: 944-52.
54. Hasegawa J, Tokuda E, Tenno T, Tsujita K, et al. 2011. SH3YL1 regulates dorsal ruffle formation by a novel phosphoinositide-binding domain. J Cell Biol 193: 901-16.
55. Marmiroli S, Bertacchini J, Beretti F, Cenni V, et al. 2009. A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward. J Cell Physiol 220: 553-61.
56. Kerr WG. 2011. Inhibitor and activator: dual functions for SHIP in immunity and cancer. Ann NY Acad Sci 1217: 1-17.
57. Marion E, Kaisaki PJ, Pouillon V, Gueydan C, et al. 2002. The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51: 2012-7.
58. van Diepen MT, Parsons M, Downes CP, Leslie NR, et al. 2009. MyosinV controls PTEN function and neuronal cell size. Nat Cell Biol 11: 1191-6.
59. Ooms LM, Horan KA, Rahman P, Seaton G, et al. 2009. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 419: 29-49.
60. Fukui K, Wada T, Kagawa S, Nagira K, et al. 2005. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 54: 1958-67.
61. Yu J, Ryan DG, Getsios S, Oliveira-Fernandes M, et al. 2008. MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci USA 105: 19300-5.
62. Brehme M, Hantschel O, Colinge J, Kaupe I, et al. 2009. Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci USA 106: 7414-9.
63. Jurynec MJ, Grunwald DJ. 2010. SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo. Dis Model Mech 3: 733-42.
64. Muraille E, Pesesse X, Kuntz C, Erneux C. 1999. Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem J 342: 697-705.
65. Pengal RA, Ganesan LP, Fang HQ, Marsh CB, et al. 2003. SHIP-2 inositol phosphatase is inducibly expressed in human monocytes and serves to regulate Fc gamma receptor-mediated signaling. J Biol Chem 278: 22657-63.
66. Wang YJ, Keogh RJ, Hunter MG, Mitchell CA, et al. 2004. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling. J Immunol 173: 6820-30.
67. Koch A, Mancini A, El BO, Tamura T. 2005. The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading. Oncogene 24: 3436-47.
68. Zhuang G, Hunter S, Hwang Y, Chen J. 2006. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via PI3 kinase-dependent Rac1 activation. J Biol Chem 282: 2683-94.
69. Habib T, Hejna JA, Moses RE, Decker SJ. 1998. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J Biol Chem 273: 18605-9.
70. Prasad N, Topping RS, Decker SJ. 2001. SH2-containing inositol 5′-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 21: 1416-28.
71. Onnockx S, De Schutter J, Blockmans M, Xie J, et al. 2008. The association between the SH2-containing inositol polyphosphate 5-phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners. J Cell Physiol 214: 260-72.
72. Cunningham DL, Sweet SM, Cooper HJ, Heath JK. 2010. Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events. J Proteome Res 9: 2317-28.
73. Xie J, Onnockx S, Vandenbroere I, Degraef C, et al. 2008. The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity. Cell Signal 20: 1432-41.
74. Hyvonen ME, Saurus P, Wasik A, Heikkila E, et al. 2010. Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes. Mol Cell Endocrinol 328: 70-9.
75. Vandenbroere I, Paternotte N, Dumont JE, Erneux C, et al. 2003. The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2. Biochem Biophys Res Commun 300: 494-500.
76. Paternotte N, Zhang J, Vandenbroere I, Backers K, et al. 2005. SHIP2 interaction with the cytoskeletal protein vinexin. FEBS J 272: 6052-66.
77. Dyson JM, O'Malley CJ, Becanovic J, Munday AD, et al. 2001. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 155: 1065-79.
78. Xie J, Vandenbroere I, Pirson I. 2008. SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF. FEBS Lett 582: 3011-7.
79. Raaijmakers JH, Deneubourg L, Rehmann H, de Koning J, et al. 2007. The PI3K effector Arap3 interacts with the PI(3, 4, 5)P3 phosphatase SHIP2 in a SAM domain-dependent manner. Cell Signal 19: 1249-57.
80. Havrylov S, Rzhepetskyy Y, Malinowska A, Drobot L, et al. 2009. Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. Proteome Sci 7: 21.
81. Mertins P, Eberl HC, Renkawitz J, Olsen JV, et al. 2008. Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics. Mol Cell Proteomics 7: 1763-77.
82. Giuriato S, Pesesse X, Bodin S, Sasaki T, et al. 2003. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3, 4, 5-trisphosphate levels. Biochem J 376: 199-207.